PhD Research Fellow in Experimental Nuclear Physics for medical applications (ref 257208)

One of the research focuses of the Nuclear Physics group is the application of nuclear physics for medical applications. This pertains to studies of novel production pathways for medically relevant radionuclides. Such radionuclides are used for a range of current cancer procedures, whereby the decay radiation is used for diagnostic and/or treatment purposes. Unlike external beam therapy, which is performed on predetermined sites on the patient, the biomolecules employed by targeted radionuclide therapy are attracted towards cancerous cells throughout the body. This enables the simultaneous treatment of unidentified, secondary malignant growths. In particular, this project is focused on emerging alpha-emitting radionuclides for targeted alpha therapy (TAT): an exciting new treatment modality for cancer.

This research topic has a clear societal impact and is one of the main research topics of the Norwegian Nuclear Research Centre (NNRC), which is focused on strengthening Norway's research capacity and competence in nuclear science. The project will be conducted in collaboration with the University of California—Berkeley, which is a partner within the NNRC and a long-standing collaborator of UiO. The candidate is expected to contribute to and take part in activities organised by the Centre.

For more information and how to apply: https://www.jobbnorge.no/en/available-jobs/job/257208/phd-research-fellow-in-experimental-nuclear-physics-for-medical-applications